Manulife (Manufacturers Life Insurance)’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $166K | Buy |
12,451
+988
| +9% | +$13.2K | ﹤0.01% | 2628 |
|
|
2025
Q1 | $117K | Sell |
11,463
-28,893
| -72% | -$294K | ﹤0.01% | 2661 |
|
|
2024
Q4 | $639K | Buy |
40,356
+23,550
| +140% | +$373K | ﹤0.01% | 2115 |
|
|
2024
Q3 | $976K | Sell |
16,806
-27
| -0.2% | -$1.57K | ﹤0.01% | 1942 |
|
|
2024
Q2 | $769K | Buy |
16,833
+2,517
| +18% | +$115K | ﹤0.01% | 1995 |
|
|
2024
Q1 | $948K | Buy |
14,316
+2,875
| +25% | +$190K | ﹤0.01% | 1886 |
|
|
2023
Q4 | $455K | Sell |
11,441
-18,433
| -62% | -$733K | ﹤0.01% | 2219 |
|
|
2023
Q3 | $952K | Buy |
29,874
+2,567
| +9% | +$81.8K | ﹤0.01% | 1762 |
|
|
2023
Q2 | $1.1M | Buy |
27,307
+1,513
| +6% | +$60.8K | ﹤0.01% | 1604 |
|
|
2023
Q1 | $1.1M | Buy |
25,794
+5,690
| +28% | +$243K | ﹤0.01% | 1583 |
|
|
2022
Q4 | $965K | Buy |
20,104
+13,293
| +195% | +$638K | ﹤0.01% | 1626 |
|
|
2022
Q3 | $256K | Buy |
+6,811
| New | +$256K | ﹤0.01% | 2406 |
|
|
2022
Q2 | – | Sell |
-6,565
| Closed | -$357K | – | 3076 |
|
|
2022
Q1 | $357K | Sell |
6,565
-1,644
| -20% | -$89.4K | ﹤0.01% | 2399 |
|
|
2021
Q4 | $480 | Sell |
8,209
-299
| -4% | -$17 | ﹤0.01% | 2291 |
|
|
2021
Q3 | $337K | Sell |
8,508
-504
| -6% | -$20K | ﹤0.01% | 2577 |
|
|
2021
Q2 | $383K | Buy |
9,012
+1,433
| +19% | +$60.9K | ﹤0.01% | 2616 |
|
|
2021
Q1 | $466K | Sell |
7,579
-152
| -2% | -$9.35K | ﹤0.01% | 2324 |
|
|
2020
Q4 | $545K | Buy |
+7,731
| New | +$545K | ﹤0.01% | 2148 |
|